Article

Subjective and objective testing demonstrate accommodative amplitude of lens

Subjective and objective accommodation in patients with a dual-optic accommodating IOL implanted bilaterally were measured in a pilot study. Accommodation was adequate in subjective testing and significantly greater than in controls with an acrylic foldable monofocal IOL. Objective evaluations demonstrated movement of the anterior optic.

Key Points

Victor Bohorquez, MD, and Ricardo Alarcon, MD, Department of Ophthalmology, ServiOftalmos, Bogota, Colombia, measured subjective and objective accommodative amplitude in 25 patients with the dual-optic IOL implanted bilaterally. The results in those patients were compared with those measured in an age-matched control group of 10 patients in whom a foldable acrylic monofocal IOL (AcrySof, Alcon Laboratories) had been implanted bilaterally.

Accommodation was investigated subjectively using push up/push down testing. Measurements for push up to first blur, push up to sustained blur, and push down were collected through the best-corrected distance visual acuity (BCDVA) at 40 cm and with use of minimum near add power.

"We also found that maximum binocular subjective accommodation achieved in the dual-optic accommodating IOL group ranged up to almost 6.0 D in push up testing, and although the accommodative amplitude values tended to be higher with the push up testing, the accommodative amplitudes achieved in push down testing are adequate for functional near vision," he noted.

Further analyses showed that the results of the first blur and sustained blur tests in patients in whom the dual-optic IOL had been implanted were significantly correlated (p = 0.002) with their distance corrected near visual acuity, i.e., more accommodation was achieved in patients with better near visual acuities.

Lens movement

The investigators also used objective techniques to evaluate the accommodating mechanism of the dual-optic IOL, including ultrasound biomicroscopy (UBM) imaging to investigate movement of the anterior lens and ray-tracing aberrometry (iTrace, Tracey Technologies) to capture changes occurring when focus was shifted from distance to near. Subjects evaluated with UBM had had the dual-optic lens implanted for at least 1 year.

UBM imaging revealed that the two optics of the implant remained in close proximity to each other, providing emmetropia, when the fellow eye was stimulated for distance vision. The anterior optic, however, moved forward when near vision was stimulated in the fellow eye using a handheld ETDRS chart.

"This technique uniquely allows measurement of the three-dimensional movement of the anterior optic in the dual-optic IOL system," Dr. Bohorquez explained.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.